SCHEMBL21362666

SCHEMBL21362666

COc1cc(C(=O)c2ccc(C(C)Br)cc2Br)c(Cl)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
LCK P06239 1/20 0.37
FYN P06241 1/20 0.37
PYGL P06737 3/20 0.35
APAF1 O14727 1/20 0.35
TDP2 O95551 1/20 0.35
NSD2 O96028 1/20 0.35
CASP3 P42574 1/20 0.35
PPP1CA P62136 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
SAE1 Q9UBE0 1/20 0.35
UBA2 Q9UBT2 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
HTR2A P28223 3/20 0.34
HTR2C P28335 3/20 0.34
AKR1C3 P42330 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20158041 0.92 RAB9A (0.39) RAB9ANPC1MAPTLCKFYN
SCHEMBL20158043 0.83 RAB9A (0.41) RAB9ANPC1MAPTLCKFYN
SCHEMBL20157488 0.81 HTT (0.49) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL20158038 0.80 CYP4F2 (0.40) RAB9ANPC1MAPTLCKFYN
SCHEMBL21564711 0.79 ALDH1A1 (0.43) RAB9ANPC1MAPTAKR1C3AKR1C2
SCHEMBL20158044 0.76 NPC1 (0.35) RAB9ANPC1MAPTLCKFYN
SCHEMBL21564942 0.73 MKNK1 (0.36) RAB9ANPC1SMN1; SMN2
SCHEMBL20158085 0.72 HTT (0.50) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL20157647 0.72 ALDH1A1 (0.44) RAB9ANPC1MAPTLCKFYN
SCHEMBL21362792 0.72 ALDH1A1 (0.44) NPC1MAPTLCKFYNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed